Letters To Government · Opinions

Big Pharma’s role in the opioid epidemic is the elephant in the room no politician wants to talk about.

G.P.D.O.T.S. has written numerous letters to government over the last six years on a wide variety of topics related to the opioid epidemic. We almost always receive some sort of response whether its a standard “thanks for your letter and we will be in touch” or a more meaningful and genuine reply to discuss the… Continue reading Big Pharma’s role in the opioid epidemic is the elephant in the room no politician wants to talk about.

Letters To Government

GPDOTS letter of concern regarding the Prescription Monitoring Program

On March 7th 2016 GPDOTS wrote the Nova Scotia Minister of Health & Wellness , College of Physicians & Surgeons , and the Prescription Monitoring Program regarding our concerns with the programs ability to identify over prescribing. Shortly after our letter Minister Leo Glavine announced he would be ordering a full review of the program.… Continue reading GPDOTS letter of concern regarding the Prescription Monitoring Program

Letters To Government

GPDOTS Letter of concern – Pharmaceutical marketing and their conflicts of interest in Canada

On June 21st, 2015 GPDOTS board of directors wrote our Federal and Provincial Ministers of Health a letter of concern regarding pharmaceutical marketing and their conflicts of interest in Canada. Please click here to view our letter <—– We encourage the public to share our letter and contact your Federal and Provincial Ministers of Health to… Continue reading GPDOTS Letter of concern – Pharmaceutical marketing and their conflicts of interest in Canada

Letters To Government · Uncategorized

GPDOTS urges Health Canada to deny approval of Zohydro

Over the past few weeks Get Prescription Drugs off the Street Society has been collecting signatures from stakeholders and the public urging Health Canada to deny the approval of the powerful new pain narcotic Zohydro ER. We would like to create as much public awareness as possible in relation to the possible approval of Zohydro… Continue reading GPDOTS urges Health Canada to deny approval of Zohydro